symptoms of combined sclerosis. His blood now showed 60 per cent. and haemoglobin 80 per cent., and it might be said to be in a condition of relative stabilitvy He showed the glossitis which he had described as the most characteristic feature in the disease.
The profession was greatly indebted to Dr. Byrom Bramwell for having made and record-ed this valuable series of observations with salvarsan. Still, his own experience had been that such results were now common as the result of strict antisepsis alone, and he had not felt it necessary to use the latter drug as its use was always attended with certain grave risks.
Mr. J. E. R. McDONAGH: Prior to the discovery of salvarsan, with the exception of some of the earlier synthetic arsenical compounds which paved the way thereto, our treatment of diseases with drugs was very largely empirical. No sooner had salvarsan been used and its wonderful therapeutic effects had been noised abroad, than the medical profession at large, knowing little of Ehrlich's chemo-therapeutic work, and being so accustomed to empiricism, had that defect so strongly stimulated that they saw in salvarsan the cure for all; with the result that it has already been employed in nearly every disease known. Ehrlich discovered that arsenic when synthetically prepared in an organic compound could be rendered non-toxic except to protozoa, and therefore that its administratrion would kill the parasites without in any way injuring the host. Salvarsan was made with the idea, then, of being an anti-protozoal drug, and experience has taught us that it is only a specific for diseases caused by that group of organisms. The protozoal diseases with which we are most familiar are yaws, recurrent fever, syphilis, malaria, and sleeping sickness. I have named them in the order in which they are most markedly benefited by the drug under discussion.
Yaws and recurrent fever need only be alluded to in passing, as neither disease is found in this country. In the Dutch West Indies and elsewhere, where there were special hospitals for yaws, since the advent of salvarsan they have been able to be closed. In certain districts in Russia where the mortality from recurrent fever was as high as 5 per cent., it has since been reduced to nil.
If malaria could be caught before the parasite had entered the sporulation stage and treated with salvarsan, no doubt every case would be cured, but unfortunately the organism has gone through several phases, as in syphilis, before the disease is attacked, with the result that certain phases which can exist in the resting stage remain uninfluenced by a series of injections and are capable of giving rise to recurrences later, by starting the cycle again. In malaria salvarsan may cut short an attack, it may cause the disappearance of a recurrence, and it may even very considerably lengthen the period between the recurrences (judged by the regular recurrences which patients were prone to have before being put under treatment), but it cannot be said to cure the disease. On most cases of the tertian form salvarsan exercises a beneficial effect, which is often reversely the case on both the tropical and quartan types. Many cases of malaria become quinineresistant, as cases of syphilis may to miercury, and in both instances this resistance can be broken down by a course of salvarsan, with the result that the first recurrence after salvarsan can be made to disappear at once with quinine, in the case of malaria, and with mercury in that of syphilis, when prior to the salvarsan treatment these respective drugs proved unavailing. A resistance to salvarsan can also be acquired by protozoa, and that is why its use in sleeping sickness has been so disappointing, because in most of the cases in which it has been tried the patient has had previous treatment with the earlier organic synthetic compounds of arsenic; nevertheless, it can be said that trypanosomes, vanish from the blood quicker, and remiiain absent over a longer period after salvarsan than after any other drug. The tendency in all protozoal diseases is no doubt to ultimate recovery, and in some few cases of malaria, syphilis and sleeping sickness recovery no doubt takes place without any treatment; and although salvarsan has been proved to have a direct destructive action upon the protozoa themselves, I am more inclined to the view that its action is rather to enhance that inherent. tendency which the host possesses towards spontaneous cure. In my opinion, this is also the mode of action of vaccines.
Vincent's angina, which is caused by a spirochete living in symbiosis with what is regarded as a bacillus, disappears at once after salvarsan. Protozoal diseases have a point in common in that they give a positive Wassermann's reaction. Therefore I propose now to consider that group of diseases in which a positive Wassermann's reaction may be obtained, but in which the cause has not been proved to be a protozoon. This group includes scarlet fever and the tubercular form of leprosy. Concerning the former, reports are increasing which testify to the beneficial effect of salvarsan provided the injection is given in the earliestW stage of the disease. As regards the latter, I can only say that I have injected three cases, without noticing in any the slightest improvement.
The next group I propose to take is one which comprises diseases which are varied in nature but common, in that arsenic is generally prescribed for them. Let us begin with psoriasis and lichen planus. On several occasions I have treated both conditions with salvarsan, but only with very marked benefit in one case of acute generalized lichen planus; the improvement I noticed in the other cases could have been equally well obtained with arsacetin, orsudan, or soamin. This has also been my experience with the various forms of leukaemia. Although there has been clinical improvement in some of my cases it was only temporary, and the patient soon relapsed into his old condition, and during no stage of the improvement did a differential blood count show any change. This has also been the case with pseudo-leukeemia cutis and mycosis fungoides, but some cases of sarcoma cutis have been reported as being cured. Another skin disease for which arsenic is invariably prescribed is pemphigus vegetans; some cases of this disease have been reported as being benefited, while others have remained uninfluenced.
The next group I will consider contains diseases the cause of which is uncertain, and in which salvarsan has been extensively tried. Smallpox, according to Marks, behaves like scarlet fever provided the patient is put under treatment in the initial stages of the disease. If given before the rash is too pronounced it will stop it from getting worse, and the patient recovers without complications. If prescribed when the rash is at its height the drug has no influence whatever on the future course of the disease. In several cases of disseminated sclerosis salvarsan has been tried, but I am unaware of a single case in which there has been even the slightest improvement. Amongst my cases of syphilis I have had one man who was a martyr to hay-fever. He had suffered from hay-fever thirteen years before he contracted syphilis, and the symptoms began invariably on May 30 for the last fifteen years. The attack was ushered in with the usual symptoms, fever, and the patient was practically blind for forty-eight hours. The hay-fever continued throughout June and July and then disappeared as quickly as it began. During the time it lasted the patient would get frequent bouts of swelling of the eyes, nose and lips, so that he would be obliged to spend days at a time in a dark room. The patient received treatment from me first in November, 1911 . As Wassermann's reaation was positive, in May, 1912, I advised patient to have some more salvarsan. On May 24, 1912, the patient began his treatment of five injections. When he received his first injection he stated that he felt that his hay-fever was coming on, and his eyes were very injected and painful.
Within forty-eight hours -of the first dose every one of his hay-fever symptoms disappeared and the patient was entirely free throughout that summer.
The last group to be considered contains diseases with a bad prognosis, in which salvarsan had been given as a last resourcenamely, malignant disease. Although Professor Czerny has written from time to time upon the good effects he has obtained in nonoperative cases of cancer, I can say, with my very limited experience, that the only condition which I have seen benefited at all was carcinoma of the tongue. This is not surprising considering that the great majority of cases of cancer of the tongue occur on a syphilitic basis, and it is the chronic active syphilitic glossitis that improves, not the epithelioma. The improvement may be maintained for a few months, so that every case of epithelioma of the tongue which supervenes on a syphilitic glossitis should certainly be given salvarsan, and every case of syphilitic glossitis with suspicious swellings and fissures should be given salvarsan before an operation is advised. I have had under my care six patients who had been advised to lose their tongue for a wrongly diagnosed epithelioma, who have been so far improved that it would now be difficult to ascertain where the suspicious lesion was situated.
In many cases of malignant disease, and especially in sarcoma, where in late cases the fear from hemmorrhage is great, death may be precipitated from this cause owing to the great vaso-dilating effect that salvarsan often exercises in diseased areas, and this explains the cause of deaths from haematemesis which have occurred after salvarsan had been prescribed in patients who were suffering from gastric ulcer. Some French observers have recently stated that salvarsan will help cases of polyarticular gonococcal arthritis; this is certainly not my experience, and I have never seen a case of gonococcal infection or a soft sore, or its complication, the ulcus molle serpiginosum, in the very slightest degree influenced by salvarsan. This also applies to tubercular affections and to the granuloma tropicum, a condition probably caused by a capsulated bacillus resembling that found in rhinoscleroma, and probably identical with the pneumobacillus.
From the ab9ve you will notice that salvarsan is a specific for protozoal diseases and may even be used as a test for determining the same. Salvarsan, according to reports, appears to be able to check the progress of diseases which, as far as our insufficient knowledge allows us to judge, we consider to be caused by the group of ultramicroscopic organisms which are provisionally ranked as -protozoa. Therefore, it might be wise to try salvarsan in early cases of anterior poliomyelitis, measles, and mumps.
In no bacterial disease does salvarsan appear to be of any use, and in those diseases of unknown origin in which arsenic is employed with benefit, little more will be derived from the administration of salvarsan than from that of orsudan, soamin, or even increasing doses of Fowler's solution.
Dr. ALEXANDER MORISON said he proposed to speak on the same lines as Dr. Byrom Bramwell had done. His first information on the employm-ent of salvarsan for pernicious ana:mia came from Dr. Bramwell at a meeting of the Society of Physicians in Glasgow in March, 1912 . It happened when he returned to London that he had a case of pernicious anaemia in his wards, the patient being a man, aged 58. He was admitted on April 1, and remained in the hospital until July, 1912. When admitted to the ward he had well-marked symptoms; his total reds were 1,331,000, whites 6,000, colour index 1,2, and he had poikilocytosis. He was given four injections intramuscularly of salvarsan at intervals of a week, each equivalent tc-gr. of arsenic, and he improved very rapidly. When he left in July he had hnmoglobin 80 per cent., the reds had risen to nearly 3 million, and his colour index was 1P5.
He resumed a light occupation. But, as such cases are apt to do, he returned, on the last day of December, in much the same condition as when he first presented himself. On this occasion, instead of giving him large doses of salvarsan, he gave him a dose equal to ,I gr. of arsenic, increasing to + gr., and he had altogether six intramuscular injections. The poikilocytosis disappeared, the reds increased to 3,200,000, the colour index was 1,2, and he had now been away from the hospital for some time. Possibly the case would relapse. Dr. Parkes Weber had referred to Hodgkin's disease, and it happened that when the case just referred to was in hospital he had also a boy, aged 15, the subject of Hodgkin's disease. He had a moderate temperature. When admitted his hmoglobin was 50 per cent., reds 31 million, whites 19,000, and he had marked symptoms of Hodgkin's disease, glands enlarged in neck, groin, &c. He had injections equal to % gr. intramuscularly. His hmoglobin percentage rose to 70, his total reds to 4 million, and his whites to 50,000. After a time this latter figure fell to 42,000. Though he remained in hospital some time, he did not think his condition was materially altered.
